Literature DB >> 17207471

Antibodies to infectious agents in individuals at ultra-high risk for psychosis.

G Paul Amminger1, Patrick D McGorry, Gregor E Berger, Darryl Wade, Alison R Yung, Lisa J Phillips, Susy M Harrigan, Shona M Francey, Robert H Yolken.   

Abstract

BACKGROUND: While there is evidence that some cases of schizophrenia may be associated with microbial infections, the role of microbial agents has not been investigated in people with emerging psychosis.
METHODS: Participants were 105 help seeking ultra-high risk individuals. Psychiatric measures included the Brief Psychiatric Rating Scale and the Scale for the Assessment of Negative Symptoms. Serum IgG antibodies against human herpesviruses and Toxoplasma gondii were determined using immunoassay methods. Multiple linear regression with adjustment for age and sex was applied to test associations between serum antibodies and psychiatric measures.
RESULTS: Higher levels of serum IgG antibodies against Toxoplasma gondii in Toxoplasma-positive individuals were significantly associated with more severe positive psychotic symptoms. No significant association was observed between antibody levels and psychiatric measures in individuals positive for human herpesviruses.
CONCLUSIONS: In some individuals infection with Toxoplasma gondii may be an environmental factor contributing to the manifestation of positive psychotic symptoms.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17207471     DOI: 10.1016/j.biopsych.2006.09.034

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  23 in total

Review 1.  Cerebrospinal fluid biomarker candidates of schizophrenia: where do we stand?

Authors:  Nenad Vasic; Bernhard J Connemann; Robert C Wolf; Hayrettin Tumani; Johannes Brettschneider
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-12-16       Impact factor: 5.270

Review 2.  The environment and susceptibility to schizophrenia.

Authors:  Alan S Brown
Journal:  Prog Neurobiol       Date:  2010-10-16       Impact factor: 11.685

3.  Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis.

Authors:  E Fuller Torrey; John J Bartko; Zhao-Rong Lun; Robert H Yolken
Journal:  Schizophr Bull       Date:  2006-11-03       Impact factor: 9.306

4.  Positive association between Toxoplasma gondii IgG serointensity and current dysphoria/hopelessness scores in the Old Order Amish: a preliminary study.

Authors:  Abhishek Wadhawan; Aline Dagdag; Allyson Duffy; Melanie L Daue; Kathy A Ryan; Lisa A Brenner; John W Stiller; Toni I Pollin; Maureen W Groer; Xuemei Huang; Christopher A Lowry; Braxton D Mitchell; Teodor T Postolache
Journal:  Pteridines       Date:  2017-11-22       Impact factor: 0.581

5.  A classification of sociomedical health indicators: perspectives for health administrators and health planners.

Authors:  A E Siegmann
Journal:  Int J Health Serv       Date:  1976       Impact factor: 1.663

6.  Serological and molecular diagnosis of Toxoplasma gondii in patients with schizophrenia.

Authors:  Adel Ebrahimzadeh; Mehdi Khoshsima Shahraki; Azad Mohammadi
Journal:  J Parasit Dis       Date:  2018-03-08

Review 7.  Toxoplasma gondii and schizophrenia: a review of published RCTs.

Authors:  Sam D Chorlton
Journal:  Parasitol Res       Date:  2017-05-15       Impact factor: 2.289

Review 8.  The cytokine model of schizophrenia: emerging therapeutic strategies.

Authors:  Ragy R Girgis; Samhita S Kumar; Alan S Brown
Journal:  Biol Psychiatry       Date:  2013-12-11       Impact factor: 13.382

9.  Structural abnormalities in the cuneus associated with Herpes Simplex Virus (type 1) infection in people at ultra high risk of developing psychosis.

Authors:  Thomas J Whitford; Stephen J Wood; Alison Yung; Luca Cocchi; Gregor Berger; Martha E Shenton; Marek Kubicki; Lisa Phillips; Dennis Velakoulis; Robert H Yolken; Christos Pantelis; Patrick McGorry; G Paul Amminger
Journal:  Schizophr Res       Date:  2012-01-12       Impact factor: 4.939

10.  Meta-Analysis of Anti-Toxoplasma gondii IgM Antibodies in Acute Psychosis.

Authors:  Joel M Monroe; Peter F Buckley; Brian J Miller
Journal:  Schizophr Bull       Date:  2014-11-09       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.